Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWetherspoon (J.D) Regulatory News (JDW)

Share Price Information for Wetherspoon (J.D) (JDW)

Share Price is delayed by 15 minutes
Get Live Data
691.50    9.00 (1.32%)
Bid:
689.50
Ask:
692.00
Spread: 2.50 (0.363%)
Market Cap: £728.88m
JDW Live PriceLast checked at - London Stock Exchange

Intraday Wetherspoon (J.D) Share Chart

Director/PDMR Shareholding

26 Mar 2020 07:00

RNS Number : 6330H
Wetherspoon (JD) PLC
25 March 2020
Β 

J D Wetherspoon plc

Β 

("the Company")

Β 

Β 

Β 

Share Incentive Plan - Unapproved Vest

Β 

The Company was informed on 24 March 2020, that following the maturity of an unapproved SIP award on 20 March 2019, ordinary shares were sold on 24 March 2020 to cover the cost of the tax and NI or to sell the whole of the share vest on the unapproved shares for the directors and PDMRs listed below. The sale price for all shares was Β£7.00 pence per share:

Β 

Β 

Shares Matured

No. of Shares Sold

Director

John Hutson

9,107

4,372

Su Cacioppo

5,112

5,112

Ben Whitley

2,189

1,029

PDMR

Β 

Β 

David Capstick

3,854

1,812

Martin Geoghegan

3,072

1,444

Miles Slade

1,896

1,896

Nigel Connor

1,247

587

James Ullman

959

461

Β 

Β 

Β 

Total Approved SIPS held in Trust (less than 3 years)

Total Unapproved SIPS held in Trust

Shareholding including SIPS held in trust (over 3 years)

Directors

Β 

Β 

Β 

John Hutson

794

33,134

136,688

Su Cacioppo

794

18,251

25,840

Ben Whitley

794

8,502

8,543

PDMR

Β 

Β 

Β 

David Capstick

794

13,489

48,226

Martin Geoghegan

794

10,829

30,657

Miles Slade

794

6,149

55

Nigel Connor

769

3,982

3,040

James Ullman

763

4,649

29,182

Β 

25 March 2020

Β 

Enquiries

Alex Bull,

PA to Finance Director

abull@jdwetherspoon.co.uk

Tel.: 01923477936

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
DSHBCGDXDDDDGGU
Date   Source Headline
24th Feb 20252:36 pmRNSDirector/PDMR Shareholding
14th Feb 20251:16 pmRNSHolding(s) in Company
3rd Feb 20257:00 amRNSTotal Voting Rights
29th Jan 20257:00 amRNSTotal Voting Rights
27th Jan 20257:00 amRNSTransaction in Own Shares
24th Jan 20257:00 amRNSTransaction in Own Shares
22nd Jan 20257:00 amRNSTrading Update Announcement
22nd Jan 20257:00 amRNSDirector/PDMR Shareholding
13th Jan 20251:04 pmRNSHolding(s) in Company
18th Dec 202412:41 pmRNSDirector/PDMR Shareholding
2nd Dec 202411:09 amRNSDirector/PDMR Shareholding
2nd Dec 20247:00 amRNSTotal Voting Rights
22nd Nov 20242:43 pmRNSDirector/PDMR Shareholding
22nd Nov 20247:00 amRNSResult of AGM - Replacement
21st Nov 20244:31 pmRNSResult of AGM
13th Nov 202410:51 amRNSTotal Voting Rights
11th Nov 20247:00 amRNSTransaction in Own Shares
8th Nov 202412:46 pmRNSDirector/PDMR Shareholding
8th Nov 20247:42 amRNSTransaction in Own Shares
7th Nov 20242:53 pmRNSDirector/PDMR Shareholding
7th Nov 20247:00 amRNSTransaction in Own Shares
6th Nov 20247:00 amRNSTrading Update Announcement
4th Nov 20248:23 amRNSHolding(s) in Company
4th Nov 20248:18 amRNSHolding(s) in Company
1st Nov 202412:36 pmRNSHolding(s) in Company
31st Oct 20244:53 pmRNSHolding(s) in Company
28th Oct 20244:00 pmRNSNotice of AGM
25th Oct 20241:51 pmRNSStatement re Press Comment
22nd Oct 20243:07 pmRNSDirector/PDMR Shareholding
18th Oct 20248:44 amRNSHolding(s) in Company
15th Oct 20249:19 amRNSDirector/PDMR Shareholding
11th Oct 202410:52 amRNSDirector/PDMR Shareholding
4th Oct 20249:50 amRNSDirector/PDMR Shareholding
4th Oct 20249:39 amRNSAnnual Financial Report
4th Oct 20247:00 amRNSPreliminary results
3rd Oct 20244:27 pmRNSHolding(s) in Company
25th Sep 20243:40 pmRNSDirector/PDMR Shareholding
16th Sep 20243:18 pmRNSHolding(s) in Company
19th Aug 202410:31 amRNSDirector/PDMR Shareholding
9th Aug 20242:56 pmRNSNews release - correction
29th Jul 202410:00 amRNSHolding(s) in Company
29th Jul 202410:00 amRNSDirector/PDMR Shareholding
22nd Jul 202411:08 amRNSDirector/PDMR Shareholding
15th Jul 20242:30 pmRNSStatement re Press Comment
11th Jul 20247:48 amRNSDirector/PDMR Shareholding
11th Jul 20247:00 amRNSReplacement Director/PDMR Shareholding
10th Jul 20244:16 pmRNSDirector/PDMR Shareholding
10th Jul 20247:00 amRNSPre-close trading update
20th Jun 202410:54 amRNSDirector/PDMR Shareholding
5th Jun 20244:21 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.